Novo Nordisk

ESPEROCT - Cost

Last Updated: April 1st, 2024

HCPCS:

J7204

HCPCS Code Descriptor:

Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu

Medicare Payment Limit:

The ESPEROCT Medicare Payment Limit is $2.111

Average Sale Price:

ESPEROCT ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The ESPEROCT Medicare Co-insurance percentage is 20%. ESPEROCT's Medicare Co-insurance amount is $0.42 per HCPCS unit.

APC Code:

The Esperoct APC Code is: 9354

APC Payment Limit:

The APC Payment Limit for ESPEROCT is available. Login to view.

Esperoct Cost Information:

ESPEROCT, a product of Novo Nordisk, became effective on July 1, 2020 and is associated with HCPCS J7204. ESPEROCT has five NDCs aligned to J7204. Most recently, pricing has remained relatively constant with only slight increases of less than 5% between 2023 and 2024.

ACCESS PRICING AND MORE BY REGISTERING

Esperoct’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Esperoct’s average wholesale price (AWP) information was last updated on:
January 1, 2024